The store will not work correctly when cookies are disabled.
2-(6-(4-fluoro-3-methylphenyl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-1-(piperidin-1-yl)ethanone
ID: ALA4588774
PubChem CID: 124176043
Max Phase: Preclinical
Molecular Formula: C21H22FN3O
Molecular Weight: 351.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(-c2cnc3ccn(CC(=O)N4CCCCC4)c3c2)ccc1F
Standard InChI: InChI=1S/C21H22FN3O/c1-15-11-16(5-6-18(15)22)17-12-20-19(23-13-17)7-10-25(20)14-21(26)24-8-3-2-4-9-24/h5-7,10-13H,2-4,8-9,14H2,1H3
Standard InChI Key: ANLDZCKRYVHYMM-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
15.2404 -1.9728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2393 -2.7923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9473 -3.2013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9455 -1.5639 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6542 -1.9692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6590 -2.7923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4434 -3.0422 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9234 -2.3733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4356 -1.7103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5313 -3.2003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8255 -2.7898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1179 -3.1971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1169 -4.0152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8292 -4.4242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5338 -4.0145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8314 -5.2414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4094 -4.4242 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17.7004 -3.8179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5007 -3.9831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7578 -4.7588 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0440 -3.3726 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.2065 -5.3693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4606 -6.1422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2604 -6.3117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8057 -5.7018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5513 -4.9225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
14 16 1 0
13 17 1 0
7 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
20 22 1 0
20 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 351.43 | Molecular Weight (Monoisotopic): 351.1747 | AlogP: 4.16 | #Rotatable Bonds: 3 |
Polar Surface Area: 38.13 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.34 | CX LogP: 3.74 | CX LogD: 3.74 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.71 | Np Likeness Score: -1.85 |
References
1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA.. (2019) 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators., 10 (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542] |